A case of a long-time survivor with chronic active Epstein-Barr virus infection

European Journal of Haematology

Volumn 72, Issue 1, 2004, Pages 73-76

  Takeoka, Yasunobu ^a   Nakao, Yoshitaka ^b   Ueda, Misako ^a   Koh, Ki Ryang ^a   Aoyama, Yasutaka ^a   Nakamae, Hirohisa ^a   Yamamura, Ryousuke ^b   Ohta, Kensuke ^a   Takubo, Takayuki ^a   Yamane, Takahisa ^a   Hino, Masayuki ^a   Tokura, Yoshiki ^c   Ishihara, Shigehiko ^d   Oshima, Koichi ^e   Kimura, Hiroshi ^f   Imashuku, Shinsaku ^g  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Higashi Osaka Seikyo Hospital   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Kashiwara Municipal Hospital   (Japan)

^e FUKUOKA UNIVERSITY   (Japan)

^f NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Bone marrow transplantation; Epstein Barr virus; Hypersensitivity to mosquito bite; Virus associated hemophagocytic syndrome

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; CYCLOSPORIN A; DEXAMETHASONE; ETOPOSIDE; GANCICLOVIR; METHYLPREDNISOLONE; STEROID;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; CAUSE OF DEATH; CHEMOTHERAPY; CHRONIC ACTIVE EPSTEIN BARR VIRUS INFECTION; CHRONIC DISEASE; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; GRAFT VERSUS HOST REACTION; HEMOPHAGOCYTIC SYNDROME; HUMAN; HYPERSENSITIVITY; INSECT BITE; LABORATORY TEST; MOSQUITO; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RELAPSE; REMISSION; SIBLING; SOUTHERN BLOTTING; SURVIVAL; SYMPTOM; TREATMENT OUTCOME; VIROGENESIS; VIRUS DETECTION; VIRUS GENOME; VIRUS INFECTION;

ADULT; ANIMALS; BITES AND STINGS; CULICIDAE; EPSTEIN-BARR VIRUS INFECTIONS; FATAL OUTCOME; FEMALE; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; HYPERSENSITIVITY; SURVIVORS; TIME FACTORS;

EID: 10744229157     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0902-4441.2004.00164.x     Document Type: Article

References (24)

1. ISHIHARA S, OKADA S, WAKIGUCHI H, KURASHIGE T, HIRAI K, KAWA-HA K. Clonal lymphoproliferation following chronic active Epstein-Barr virus infection and hypersensitivity to mosquito bites. Am J Hematol 1997;54:276-281.
2. ISHIHARA S, OKADA S, WAKIGUCHI H, KURASHIGE T, MORISHIMA T, KAWA-HA K. Chronic active Epstein-Barr virus infection in children in Japan. Acta Paediatr 1995;84:1271-1275.
3. ISHIHARA S, YABUTA R, TOKURA Y, OHSHIMA K, TAGAWA S. Hypersensitivity to mosquito bites is not an allergic disease, but an Epstein-Barr virus-associated lymphoproliferative disease. Int J Hematol 2000;72:223-228.
4. KIMURA H, HOSHINO Y, KANEGANE H, TSUGE I, OKAMURA T, KAWA K, MORISHIMA T. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood 2001;98:280-286.
5. KAWA K. Epstein-Barr virus-associated disease in humans. Int J Hematol 2000;71:108-117.
6. SCHOOLEY RT, CAREY RW, MILLER G, HENLE W, EASTMAN R, MARK EJ, KENYON K, WHEELER EO, RUBIN RH. Chronic Epstein-Barr virus infection associated with fever and interstitial pneumonitis. Clinical and serologic features and response to antiviral chemotherapy. Ann Intern Med 1986;104:636-643.
7. JONES J, SHURIN S, ABRAMOWSKY C, TUBBS RR, SCIOTTO CG, WAHL R, SANDS J, GOTTMAN D, KATZ BZ, SKLAR J. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 1988;318:733-741.
8. KIKUTA H, TAGUCHI Y, TOMIZAWA K et al. Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature 1988;333:455-457.
9. OKANO M, MATSUMOTO S, OSATO T, SAKIYAMA Y, THIELE GM, PURTILO DT. Severe chronic active Epstein-Barr virus infection syndrome. Clin Microbiol Rev 1991;4:129-135.
10. OHGA S, TAKADA H, HONDA K, INAMURA T, GONDO K, OHSHIMA K, YAMAMOTO M, HARA T. Central nervous system T-cell lymphoproliferative disorder in a patient with chronic active Epstein-Barr virus infection. J Pediatr Hematol Oncol 1999;21:42-46.
11. KAWA-HA K, ISHIHARA S, NINOMIYA T, YUMURA-YAGI K, HARA J, MURAYAMA F, TAWA A, HIRAI K. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest 1989;84:51-55.
12. IMAI S, SUGIURA M, OIKAWA O et al. Epstein-Barr virus (EBV)-carrying and -expressing T-cell lines established from severe chronic active EBV infection. Blood 1996;87:1446-1457.
13. KANEGANE H, BHATIA K, GUTIERREZ M et al. A syndrome of peripheral blood T-cell infection with Epstein-Barr virus (EBV) followed by EBV-positive T-cell lymphoma. Blood 1998;91:2085-2091.
14. QUINTANILLA-MARTINEZ L, KUMAR S, FEND F et al. T-cell lymphoproliferative disorder following acute/chronic EBV infection: a distinct clinicopathologic syndrome. Blood 2000;96:443-451.
15. IMASHUKU S, HIBI S, OHARA T et al. Effective control of Epstein-Barr virus-related hemophagocytic lymphohistiocytosis with immuno-chemotherapy. Blood 1999;93:1869-1874.
16. BLANCHE S, CANIGLIA M, GIRAULT D, LANDMAN J, GRISCELLI C, FISCHER A. Treatment of hemophagocytic lymphohistiocytosis with chemotherapy and bone marrow transplantation: a single-center study of 22 cases. Blood 1991;78:51-54.
17. IMASHUKU S, HIBI S, TODO S et al. Allogeneic hematopoietic stem cell transplantation for patients with hemophagocytic syndrome (HPS) in Japan. Bone Marrow Transplant 1999;23:569-572.
18. IMASHUKU S, NAYA M, YAMORI M, NAKABAYASHI Y, HOJO M, KIHARA A, TABATA Y, AKIOKA C, HIBI S, TODO S. Bone marow transplantation for Epstein-Barr virus-related clonal T cell proliferation associated with hemophagocytosis. Bone Marrow Transplant 1997;19:1059-1060.
19. TAKAMI A, NAKAO S, YACHIE A et al. Successful treatment of Epstein-Barr virus-associated natural killer cell large granular lymphocytic leukaemia using allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 1998;21:1279-1282.
20. TESHIMA T, MIYAJI R, FUKUDA M, OHSHIMA K. Bone marrow transplantation for Epstein-Barr virus-associated natural killer cell large granular lymphocyte leukaemia. Lancet 1996;347:1124.
21. OKAMURA T, KISHIMOTO T, INOUE M et al. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease. Bone Marrow Transplant 2003;31:105-111.
22. KIMURA H, MORISHIMA T, KANEGANE H et al. Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis 2003;187:527-533.
23. SEO N, TOKURA Y, ISHIHARA S, TAKEOKA Y, TAGAWA S, TAKIGAWA M. Disordered expression of inhibitory receptors on the NK1-type natural killer (NK) leukaemic cells from patients with hypersensitivity to mosquito bites. Clin Exp Immunol 2000;120:413-419.
24. KASAHARA Y, YACHIE A, TAKEI K et al. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood 2001;98:1882-1888.